Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» BRAF V600
BRAF V600
Novartis: FDA OKs Tafinlar + Mekinist For Solid Tumors With BRAF V600E Mutation
NASDAQ
Thu, 06/23/22 - 10:57 am
Novartis
FDA
Tafinlar+Mekinist
solid tumors
BRAF V600
Novartis picks up FDA approval for targeted lung cancer meds Tafinlar, Mekinist
Fierce Pharma
Fri, 06/23/17 - 03:35 pm
Novartis
FDA
Tafinlar
Mekinist
non-small cell lung cancer
BRAF V600
Novartis' targeted meds Tafinlar, Mekinist pick up EU combo approval in lung cancer
Fierce Pharma
Wed, 04/5/17 - 12:07 pm
Novartis
Europe
Tafinlar
Mekinist
lung cancer
BRAF V600
Genentech, Exelixis score another PhIII success for cobimetinib
Fierce Biotech
Tue, 10/6/15 - 09:59 am
Genentech
Exelixis
Cobimetinib
melanoma
BRAF V600